SPCE - Hot Stocks: SPCE continues to fall; AVGO MDB rise on earnings; IMPL gets FDA approval; FBRX abandons drug

A wide variety of news items drove some high-profile moves in Friday's midday trading. Earnings remained a key theme, with Broadcom (NASDAQ:AVGO) and MongoDB (NASDAQ:MDB) both posting gains on strong quarterly reports. Elsewhere, Impel NeuroPharma (NASDAQ:IMPL) recorded a double-digit percentage rally after it received FDA approval for a key product. Turning to some of the day's notable losers, shares of Forte Bio (NASDAQ:FBRX) surrendered more than four-fifths of their value after a failed clinical trial forced it to drop the development of a product. Meanwhile, Richard Branson's space-tourism company Virgin Galactic (NYSE:SPCE) extended its recent slide as investors continued to react to news of a regulatory investigation of the billionaire's headline-grabbing flight in July. Gainers Broadcom's (AVGO) quarterly profit edged past expectations on revenue that rose nearly 17% from last year. The company also provided a strong forecast for the current quarter. AVGO advanced 1% in midday trading. MongoDB (MDB)

For further details see:

Hot Stocks: SPCE continues to fall; AVGO, MDB rise on earnings; IMPL gets FDA approval; FBRX abandons drug